Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling

Guie Xie(Sun Yat-sen University), Can Liao(Guangzhou Medical University)
Oncology Letters
March 16, 2016
Cited by 25


Related Papers